Another ADC Buyout - Just not SPL, page-19

Good post. I’ve been thinking about this a bit myself but take the different view from yourself in that I believe along with the proof of concept now having been established and the fact that Merck have been playing with our dendrimers for 3 years, signifies to me that they are still very much interested in our tec. 1yr is a good enough amount of time to have determined their value, to still be playing with them today, suggests to me they want them. Could partly explain the blackout period on the executive buying. They may well be in negotiations right now. If they were not interested in continuing their current research agreements they would have abandoned them long ago. Game on I reckon.